Invesco’s Accretive Health AH Stock Holding History

Invesco’s Portfolio AH Stock Details AH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-3,424	Closed	-$32K	–	4434
2013 Q4	$32K	Sell	3,424 -360	-10%	-$3.1K	﹤0.01%	4128
2013 Q3	$34K	Buy	3,784 +1,500	+66%	+$14.9K	﹤0.01%	4119
2013 Q2	$24K	Buy	+2,284	New	+$24K	﹤0.01%	4117

Other funds holding AH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JRP

Jasper Ridge Partners Menlo Park, California $4.69B AUM 31.34% 1-Year Est. Return

ICM

Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

SCA

SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Amici Capital New York $257M AUM 4.88% 1-Year Est. Return

Invesco's AH Position: Q1 2014 in Review

Invesco sold out of Accretive Health (AH) in Q1 2014, closing a stake of 3,424 shares — an estimated $32K sold.

Invesco first reported a position in AH in Q2 2013 and held it in 3 quarters. The position peaked at $34K in Q3 2013. 66 funds tracked by Wall St. Rank hold AH as of Q1 2014.

Invesco reported no remaining Accretive Health position as of Q1 2014 after selling out during the quarter.
Invesco sold 3,424 Accretive Health shares in Q1 2014, an estimated $32K.
Invesco first reported a position in Accretive Health in Q2 2013 and held it in 3 quarters.
Invesco's Accretive Health position peaked at $34K in Q3 2013.
66 funds tracked by Wall St. Rank held Accretive Health as of Q1 2014.

Based on Invesco's 13F filing for Q1 2014, filed 15 May 2014.